SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-013106
Filing Date
2024-04-04
Accepted
2024-04-04 06:30:23
Documents
16
Period of Report
2024-04-04

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 19110
2 ex99-1.htm EX-99.1 12169
3 ex99-1_001.jpg GRAPHIC 439124
4 ex99-1_002.jpg GRAPHIC 541350
5 ex99-1_003.jpg GRAPHIC 260815
6 ex99-1_004.jpg GRAPHIC 280413
7 ex99-1_005.jpg GRAPHIC 233317
8 ex99-1_006.jpg GRAPHIC 292028
9 ex99-1_007.jpg GRAPHIC 262188
10 ex99-1_008.jpg GRAPHIC 227671
11 ex99-1_009.jpg GRAPHIC 217621
12 ex99-1_010.jpg GRAPHIC 162493
13 ex99-1_011.jpg GRAPHIC 157800
14 ex99-1_012.jpg GRAPHIC 222787
15 ex99-1_013.jpg GRAPHIC 157253
16 ex99-1_014.jpg GRAPHIC 256143
  Complete submission text file 0001493152-24-013106.txt   5144269
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 24821574
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)